Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02579876 · ClinicalTrials.gov registry record · Phase 2
Milk Patch for Eosinophilic Esophagitis
A Phase 2 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT02579876 is a Phase 2 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 20 participants.
The verdict
NCT02579876, a Phase 2 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a single-site, double-blind, placebo-controlled, randomized trial to study efficacy and safety of the Viaskin® Milk Patch for children with milk induced Eosinophilic Esophagitis (EoE). 20 subjects will be randomized 3:1 to Viaskin® Milk or placebo patch.
Interventions
- DRUG Viaskin Milk 500 mcg
- DRUG Viaskin Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-10 |
| Est. Completion | 2018-11-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02579876
The ClinicalTrials.gov registry entry for NCT02579876 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Viaskin Milk 500 mcg is the first listed.
NCT02579876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02579876 about?
NCT02579876 is a clinical study titled "Milk Patch for Eosinophilic Esophagitis". This is a single-site, double-blind, placebo-controlled, randomized trial to study efficacy and safety of the Viaskin® Milk Patch for children with milk induced Eosinophilic Esophagitis (EoE). 20 subjects will be randomized 3:1 to Viaskin® Milk or placebo patch.
What is the current status of trial NCT02579876?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2015-10. Estimated completion is 2018-11-20.
What interventions are being tested in trial NCT02579876?
The interventions under investigation include: Viaskin Milk 500 mcg (DRUG), Viaskin Placebo (DRUG).
Who is sponsoring clinical trial NCT02579876?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.